Abstract

The overall goal of this new Knowledge Transfer Unit (KTU) is to better inform the medical community, patients, and their families about schizophrenia. There are 4 aims of the KTU. First is to improve the recognition of prodromal and early signs of schizophrenia and stress the importance of early intervention. Second is to improve knowledge and utilization of best treatments for schizophrenia. Third is to improve knowledge about the size effects of anti-schizophrenia medications. Finally, the KTU aims to increase the knowledge concerning poor treatment response and the role of clozapine in the method of """"""""academic detailing"""""""" seems to be a worthy intellectual centerpiece for this unit. The leaders of the KTU are both junior, and there are examples of issues that seem internalized.

  Funding Agency

Agency
National Institute of Health (NIH)
Institute
National Institute of Mental Health (NIMH)
Type
Center Core Grants (P30)
Project #
5P30MH060575-02
Application #
6434459
Study Section
Special Emphasis Panel (ZMH1)
Project Start
2001-02-01
Project End
2002-01-31
Budget Start
Budget End
Support Year
2
Fiscal Year
2001
Total Cost
$175,215
Indirect Cost

  Institution

Name
Long Island Jewish Medical Center
Department
Type
DUNS #
City
New Hyde Park
State
NY
Country
United States
Zip Code
11040

  Publications

DeRosse, Pamela; Nitzburg, George C; Kompancaril, Bernie et al. (2014) The relation between childhood maltreatment and psychosis in patients with schizophrenia and non-psychiatric controls. Schizophr Res 155:66-71
Wellington, Robin L; Bilder, Robert M; Napolitano, Barbara et al. (2013) Effects of age on prefrontal subregions and hippocampal volumes in young and middle-aged healthy humans. Hum Brain Mapp 34:2129-40
Kane, John M; Kishimoto, Taishiro; Correll, Christoph U (2013) Assessing the comparative effectiveness of long-acting injectable vs. oral antipsychotic medications in the prevention of relapse provides a case study in comparative effectiveness research in psychiatry. J Clin Epidemiol 66:S37-41
Ardekani, Babak A; Tabesh, Ali; Sevy, Serge et al. (2011) Diffusion tensor imaging reliably differentiates patients with schizophrenia from healthy volunteers. Hum Brain Mapp 32:1-9
Woerner, Margaret G; Correll, Christoph U; Alvir, Jose Ma J et al. (2011) Incidence of tardive dyskinesia with risperidone or olanzapine in the elderly: results from a 2-year, prospective study in antipsychotic-naïve patients. Neuropsychopharmacology 36:1738-46
Lencz, Todd; Robinson, Delbert G; Napolitano, Barbara et al. (2010) DRD2 promoter region variation predicts antipsychotic-induced weight gain in first episode schizophrenia. Pharmacogenet Genomics 20:569-72
Coscia, Denise M; Narr, Katherine L; Robinson, Delbert G et al. (2009) Volumetric and shape analysis of the thalamus in first-episode schizophrenia. Hum Brain Mapp 30:1236-45
Lencz, Todd; Lipsky, Robert H; DeRosse, Pamela et al. (2009) Molecular differentiation of schizoaffective disorder from schizophrenia using BDNF haplotypes. Br J Psychiatry 194:313-8
Szeszko, Philip R; Hodgkinson, Colin A; Robinson, Delbert G et al. (2008) DISC1 is associated with prefrontal cortical gray matter and positive symptoms in schizophrenia. Biol Psychol 79:103-10
Szeszko, Philip R; Robinson, Delbert G; Ashtari, Manzar et al. (2008) Clinical and neuropsychological correlates of white matter abnormalities in recent onset schizophrenia. Neuropsychopharmacology 33:976-84

Showing the most recent 10 out of 44 publications